Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of allergenic extracts of Platanus acerifolia, Salsola kali, Chenopodium album and Artemisia vulgaris
2013-003892-36Phase 2Completed
- Sponsor
- Inmunal
- Start
- Apr 2015
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of platanus acerifolia allergen extract, Avanz Salsola kali, chenopodium album allergen extract and artemisia vulgaris pollen allergen extract in allergic rhinitis (AR), allergic conjunctivitis (AC), allergic asthma and 1 more (4 arms), sponsored by Inmunal. Primary endpoint: Cutaneous reaction to the extract. Started Apr 2015; status: completed.
02
Drugs
platanus acerifolia allergen extractAvanz Salsola kalichenopodium album allergen extractartemisia vulgaris pollen allergen extract
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)allergic asthmapollinosis
Beyond the preview
Go deeper on 2013-003892-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003892-36.